The Price of Safer Chemistry: Confronting the Scale Economics That Keep Hazardous Substances Entrenched—and the Strategies Beginning to Change the Equation
Safer chemical alternatives routinely outperform their hazardous predecessors in laboratory settings, yet they continue to struggle against the entrenched cost advantages of incumbent substances when deployed at commercial scale. The barriers are real, structural, and persistent—but a convergence of funding models, regulatory incentives, and industry consortia is beginning to shift the economics. This analysis examines both the depth of the problem and the emerging pathways through it.
Sep 28, 2026